ArticleInternational ophthalmology2023

Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19.

Jyoti Shakrawal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.